The term neoplasm refers to an abnormal mass of tissue that forms when cells grow and divide more than they should, or do not die when they should. The growth of this “new tissue” is uncoordinated with that of the normal surrounding tissue and persists in the same excessive manner even after the cessation of the stimuli which evoked the change. Neoplasms are broadly categorized clinically and histologically into benign (non-cancerous, localized, non-invasive), premalignant (such as carcinoma in situ or severe dysplasia), and malignant (cancerous, capable of invading surrounding structures and distant metastasis).
The roots combine directly to mean “new formation.” The term was introduced into English medical literature in the mid-to-late 19th century as cellular pathology advanced, providing a scientific descriptor for what laypeople and early physicians called “tumors.”
🔀 ALIASES / ALTERNATE TERMS
Tumor(originally meant any swelling, but now used synonymously with solid neoplasms)
Mass
New growth
Lesion(broad term, can include non-neoplastic conditions)
Nodule
Polyp(a macroscopic descriptive term for a neoplasm projecting from a mucosal surface)
🔗 RELATED TERMS
Carcinoma — a malignant neoplasm arising from epithelial tissue.
Sarcoma — a malignant neoplasm arising from mesenchymal/connective tissue (bone, muscle, fat).
benign — a non-malignant neoplasm that does not invade or metastasize.
malignant — a cancerous neoplasm characterized by uncontrolled growth, invasion, and potential metastasis.
Metastasis — the spread of malignant neoplastic cells to secondary, distant organs.
hyperplasia — an increase in the number of normal cells in a tissue, which is a physiologic or appropriate response, unlike the uncontrolled growth in neoplasia.
Dysplasia — abnormal cellular development or organization, often considered a precursor to malignant neoplasia.
Oncology — the medical specialty dedicated to the study, diagnosis, and treatment of neoplasms.
Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance
Level IV - Surgical pathology, gross and microscopic examination (the standard path evaluation to determine benign vs. malignant)
⚠️ Coding Note: In ICD-10-CM, coding for a neoplasm requires utilizing the Table of Neoplasms. You must determine the site and the behavior: Malignant Primary, Malignant Secondary, Ca in situ, Benign, Uncertain, or Unspecified.
Uncertain behavior (D37-D48) means the pathologist has examined the tissue and cannot predict whether it is benign or malignant.
Unspecified behavior (D49) means the physician simply documented “tumor” or “mass” without providing the pathology results or definitive diagnosis. Always query the provider or wait for the pathology report if a definitive diagnosis is pending before applying an “Unspecified” code.